## **Core Concept**
cGMP (cyclic guanosine monophosphate) serves as a crucial second messenger in cellular signaling pathways. It is involved in transmitting signals from a variety of extracellular stimuli to intracellular effectors. The primary hormone associated with cGMP as a second messenger is **nitric oxide (NO)**, but in the context of the given options, we are likely discussing its role related to **natriuretic peptides** and **nitric oxide**.

## **Why the Correct Answer is Right**
The correct answer, **B. ANP (Atrial Natriuretic Peptide)**, is right because ANP exerts its effects through the activation of **guanylyl cyclase** receptors on the surface of target cells. This activation leads to an increase in intracellular cGMP levels, which in turn triggers a series of downstream effects, including **vasodilation** and **natriuresis**. These effects are critical in regulating blood pressure and electrolyte balance.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **nitric oxide (NO)** does indeed use cGMP as a second messenger, its mechanism involves the activation of soluble guanylyl cyclase in target cells, not through a receptor directly as implied for the listed hormones. However, it's closely related to cGMP signaling.
- **Option C:** **Vasopressin** primarily acts through **V1** and **V2 receptors**, which are coupled to **G proteins**, leading to various signaling cascades but not directly through cGMP as a primary second messenger.
- **Option D:** **Insulin** acts through its receptor, which has intrinsic tyrosine kinase activity, leading to a cascade of phosphorylation events. Its signaling pathway does not primarily involve cGMP.

## **Clinical Pearl / High-Yield Fact**
A key clinical correlation is that **ANP and BNP (Brain Natriuretic Peptide)**, which are structurally related to ANP, are used as biomarkers for **heart failure**. Their levels are elevated in heart failure and can guide diagnosis and treatment.

## **Correct Answer:** . **Atrial Natriuretic Peptide (ANP)**